Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 155

1.

The Interaction of Helicobacter pylori with TFF1 and Its Role in Mediating the Tropism of the Bacteria Within the Stomach.

Clyne M, May FEB.

Int J Mol Sci. 2019 Sep 7;20(18). pii: E4400. doi: 10.3390/ijms20184400. Review.

2.

Binding of Helicobacter pylori to Human Gastric Mucins Correlates with Binding of TFF1.

Dunne C, Naughton J, Duggan G, Loughrey C, Kilcoyne M, Joshi L, Carrington S, Earley H, Backert S, Robbe Masselot C, May FEB, Clyne M.

Microorganisms. 2018 May 18;6(2). pii: E44. doi: 10.3390/microorganisms6020044.

3.
4.

Does radiation-induced c-MYC amplification initiate breast oncogenesis?

Wade MA, May FE, Onel K, Allan JM.

Mol Cell Oncol. 2015 Feb 3;3(1):e1010950. doi: 10.1080/23723556.2015.1010950. eCollection 2016 Jan-Feb.

6.

Common cancer-associated imbalances in the DNA damage response confer sensitivity to single agent ATR inhibition.

Middleton FK, Patterson MJ, Elstob CJ, Fordham S, Herriott A, Wade MA, McCormick A, Edmondson R, May FE, Allan JM, Pollard JR, Curtin NJ.

Oncotarget. 2015 Oct 20;6(32):32396-409. doi: 10.18632/oncotarget.6136.

7.

High-resolution imaging for the detection and characterisation of circulating tumour cells from patients with oesophageal, hepatocellular, thyroid and ovarian cancers.

Dent BM, Ogle LF, O'Donnell RL, Hayes N, Malik U, Curtin NJ, Boddy AV, Plummer ER, Edmondson RJ, Reeves HL, May FE, Jamieson D.

Int J Cancer. 2016 Jan 1;138(1):206-16. doi: 10.1002/ijc.29680. Epub 2015 Aug 19.

8.

TFF3 is a valuable predictive biomarker of endocrine response in metastatic breast cancer.

May FE, Westley BR.

Endocr Relat Cancer. 2015 Jun;22(3):465-79. doi: 10.1530/ERC-15-0129. Epub 2015 Apr 21.

9.

c-MYC is a radiosensitive locus in human breast cells.

Wade MA, Sunter NJ, Fordham SE, Long A, Masic D, Russell LJ, Harrison CJ, Rand V, Elstob C, Bown N, Rowe D, Lowe C, Cuthbert G, Bennett S, Crosier S, Bacon CM, Onel K, Scott K, Scott D, Travis LB, May FE, Allan JM.

Oncogene. 2015 Sep 17;34(38):4985-94. doi: 10.1038/onc.2014.427. Epub 2014 Dec 22.

10.

Novel drugs that target the estrogen-related receptor alpha: their therapeutic potential in breast cancer.

May FE.

Cancer Manag Res. 2014 May 23;6:225-52. doi: 10.2147/CMAR.S35024. eCollection 2014. Review.

11.

A twenty-first century cancer epidemic caused by obesity: the involvement of insulin, diabetes, and insulin-like growth factors.

Westley RL, May FE.

Int J Endocrinol. 2013;2013:632461. doi: 10.1155/2013/632461. Epub 2013 Jul 31.

12.

The interaction of Helicobacter pylori with the adherent mucus gel layer secreted by polarized HT29-MTX-E12 cells.

Dolan B, Naughton J, Tegtmeyer N, May FE, Clyne M.

PLoS One. 2012;7(10):e47300. doi: 10.1371/journal.pone.0047300. Epub 2012 Oct 8.

13.

The potential of trefoil proteins as biomarkers in human cancer.

May FE.

Biomark Med. 2012 Jun;6(3):301-4. doi: 10.2217/bmm.12.22. No abstract available.

14.

Tartrazine and sunset yellow are xenoestrogens in a new screening assay to identify modulators of human oestrogen receptor transcriptional activity.

Axon A, May FE, Gaughan LE, Williams FM, Blain PG, Wright MC.

Toxicology. 2012 Aug 16;298(1-3):40-51. doi: 10.1016/j.tox.2012.04.014. Epub 2012 May 3.

PMID:
22562034
15.

TFF3 is a normal breast epithelial protein and is associated with differentiated phenotype in early breast cancer but predisposes to invasion and metastasis in advanced disease.

Ahmed AR, Griffiths AB, Tilby MT, Westley BR, May FE.

Am J Pathol. 2012 Mar;180(3):904-16. doi: 10.1016/j.ajpath.2011.11.022. Epub 2012 Feb 16.

PMID:
22341453
16.

Two minor NQO1 and NQO2 alleles predict poor response of breast cancer patients to adjuvant doxorubicin and cyclophosphamide therapy.

Jamieson D, Cresti N, Bray J, Sludden J, Griffin MJ, Hawsawi NM, Famie E, Mould EV, Verrill MW, May FE, Boddy AV.

Pharmacogenet Genomics. 2011 Dec;21(12):808-19. doi: 10.1097/FPC.0b013e32834b6918.

PMID:
21946896
17.

Trefoil factor 1 stimulates both pancreatic cancer and stellate cells and increases metastasis.

Arumugam T, Brandt W, Ramachandran V, Moore TT, Wang H, May FE, Westley BR, Hwang RF, Logsdon CD.

Pancreas. 2011 Aug;40(6):815-22. doi: 10.1097/MPA.0b013e31821f6927.

18.
19.

Estrogen regulates vesicle trafficking gene expression in EFF-3, EFM-19 and MCF-7 breast cancer cells.

Wright PK, May FE, Darby S, Saif R, Lennard TW, Westley BR.

Int J Clin Exp Pathol. 2009;2(5):463-75. Epub 2009 Jan 30.

20.

Increased expression of both insulin receptor substrates 1 and 2 confers increased sensitivity to IGF-1 stimulated cell migration.

de Blaquière GE, May FE, Westley BR.

Endocr Relat Cancer. 2009 Jun;16(2):635-47. doi: 10.1677/ERC-08-0216. Epub 2009 Mar 4.

PMID:
19261680
21.

Helicobacter pylori lipopolysaccharide interacts with TFF1 in a pH-dependent manner.

Reeves EP, Ali T, Leonard P, Hearty S, O'Kennedy R, May FE, Westley BR, Josenhans C, Rust M, Suerbaum S, Smith A, Drumm B, Clyne M.

Gastroenterology. 2008 Dec;135(6):2043-54, 2054.e1-2. doi: 10.1053/j.gastro.2008.08.049. Epub 2008 Sep 3.

PMID:
18848942
22.
23.

Decreased expression of gastrokine 1 and the trefoil factor interacting protein TFIZ1/GKN2 in gastric cancer: influence of tumor histology and relationship to prognosis.

Moss SF, Lee JW, Sabo E, Rubin AK, Rommel J, Westley BR, May FE, Gao J, Meitner PA, Tavares R, Resnick MB.

Clin Cancer Res. 2008 Jul 1;14(13):4161-7. doi: 10.1158/1078-0432.CCR-07-4381.

24.

Increased TFF1 trefoil protein expression in Opisthorchis viverrini-associated cholangiocarcinoma is important for invasive promotion.

Thuwajit P, Chawengrattanachot W, Thuwajit C, Sripa B, May FE, Westley BR, Tepsiri NN, Paupairoj A, Chau-In S.

Hepatol Res. 2007 Apr;37(4):295-304.

PMID:
17397518
25.

Identification of steroid hormone-regulated genes in breast cancer.

Westley BR, May FE.

Methods Mol Med. 2006;120:363-88.

PMID:
16491612
26.

Structure of mammalian trefoil factors and functional insights.

Thim L, May FE.

Cell Mol Life Sci. 2005 Dec;62(24):2956-73. Review.

PMID:
16374584
27.

Human pancreatic polypeptide has a marked diurnal rhythm that is affected by ageing and is associated with the gastric TFF2 circadian rhythm.

Johns CE, Newton JL, Westley BR, May FE.

Peptides. 2006 Jun;27(6):1341-8. Epub 2005 Dec 15.

PMID:
16359755
28.

Identification of human urinary trefoil factor 1 as a novel calcium oxalate crystal growth inhibitor.

Chutipongtanate S, Nakagawa Y, Sritippayawan S, Pittayamateekul J, Parichatikanond P, Westley BR, May FE, Malasit P, Thongboonkerd V.

J Clin Invest. 2005 Dec;115(12):3613-22. Epub 2005 Nov 23.

29.

Trefoil factor family mRNA and protein expression in pterygium.

Lafontaine PO, Arnal M, Buron N, Solary E, Bron AM, Westley BR, May FE, Bara J, Gespach C, Creuzot-Garcher C.

Int J Oncol. 2005 Oct;27(4):997-1003.

PMID:
16142316
31.
32.

Trefoil factor family peptide 3 prevents the development and promotes healing of ischemia-reperfusion injury in weanling rats.

Carrasco R, Pera M, May FE, Westley BR, Martinez A, Morales L.

J Pediatr Surg. 2004 Nov;39(11):1693-700.

PMID:
15547836
33.

Do benefits and barriers differ by stage of adoption for colorectal cancer screening?

Rawl SM, Menon U, Champion VL, May FE, Loehrer P Sr, Hunter C, Azzouz F, Monahan PO, Skinner CS.

Health Educ Res. 2005 Apr;20(2):137-48. Epub 2004 Aug 16.

PMID:
15314036
34.

The trefoil protein TFF1 is bound to MUC5AC in human gastric mucosa.

Ruchaud-Sparagano MH, Westley BR, May FE.

Cell Mol Life Sci. 2004 Aug;61(15):1946-54.

PMID:
15289936
35.

Expression and motogenic activity of TFF2 in human breast cancer cells.

May FE, Semple JI, Prest SJ, Westley BR.

Peptides. 2004 May;25(5):865-72.

PMID:
15177883
36.

Synergistic effects of systemic trefoil factor family 1 (TFF1) peptide and epidermal growth factor in a rat model of colitis.

FitzGerald AJ, Pu M, Marchbank T, Westley BR, May FE, Boyle J, Yadollahi-Farsani M, Ghosh S, Playford RJ.

Peptides. 2004 May;25(5):793-801.

PMID:
15177874
37.

Development of a two-site ELISA assay for the dimeric form of human TFF1.

Pu M, May FE, Playford RJ, Ruchaud-Sparagano MH, Westley BR.

Peptides. 2004 May;25(5):731-6.

PMID:
15177866
38.

Helicobacter pylori interacts with the human single-domain trefoil protein TFF1.

Clyne M, Dillon P, Daly S, O'Kennedy R, May FE, Westley BR, Drumm B.

Proc Natl Acad Sci U S A. 2004 May 11;101(19):7409-14. Epub 2004 May 3.

40.

Review article: the ageing bowel and intolerance to aspirin.

Newton JL, Johns CE, May FE.

Aliment Pharmacol Ther. 2004 Jan 1;19(1):39-45. Review.

41.

Trefoil peptide TFF2 treatment reduces VCAM-1 expression and leukocyte recruitment in experimental intestinal inflammation.

Soriano-Izquierdo A, Gironella M, Massaguer A, May FE, Salas A, Sans M, Poulsom R, Thim L, Piqué JM, Panés J.

J Leukoc Biol. 2004 Feb;75(2):214-23. Epub 2003 Nov 3.

PMID:
14597729
42.

Selective abrogation of the proinvasive activity of the trefoil peptides pS2 and spasmolytic polypeptide by disruption of the EGF receptor signaling pathways in kidney and colonic cancer cells.

Rodrigues S, Attoub S, Nguyen QD, Bruyneel E, Rodrigue CM, Westley BR, May FE, Thim L, Mareel M, Emami S, Gespach C.

Oncogene. 2003 Jul 17;22(29):4488-97.

PMID:
12881705
44.

Trefoil peptides as proangiogenic factors in vivo and in vitro: implication of cyclooxygenase-2 and EGF receptor signaling.

Rodrigues S, Van Aken E, Van Bocxlaer S, Attoub S, Nguyen QD, Bruyneel E, Westley BR, May FE, Thim L, Mareel M, Gespach C, Emami S.

FASEB J. 2003 Jan;17(1):7-16.

PMID:
12522107
45.

The estrogen-regulated protein, TFF1, stimulates migration of human breast cancer cells.

Prest SJ, May FE, Westley BR.

FASEB J. 2002 Apr;16(6):592-4.

PMID:
11919164
46.

High expression of the trefoil protein TFF1 in interval breast cancers.

Crosier M, Scott D, Wilson RG, Griffiths CD, May FE, Westley BR.

Am J Pathol. 2001 Jul;159(1):215-21.

47.
48.

The solution structure of the disulphide-linked homodimer of the human trefoil protein TFF1.

Williams MA, Westley BR, May FE, Feeney J.

FEBS Lett. 2001 Mar 30;493(2-3):70-4.

49.
50.

The human two domain trefoil protein, TFF2, is glycosylated in vivo in the stomach.

May FE, Semple JI, Newton JL, Westley BR.

Gut. 2000 Apr;46(4):454-9.

Supplemental Content

Support Center